BioNTech
BNTX
284 hedge funds and large institutions have $7.84B invested in BioNTech in 2021 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 72 increasing their positions, 81 reducing their positions, and 37 closing their positions.
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
157% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 37
141% more capital invested
Capital invested by funds: $3.25B → $7.84B (+$4.59B)
26% more funds holding
Funds holding: 226 → 284 (+58)
2.12% more ownership
Funds ownership: 12.54% → 14.66% (+2.1%)
11% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 81
33% less call options, than puts
Call options by funds: $754M | Put options by funds: $1.12B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$561M |
| 2 |
FI
Fosun International
Hong Kong,
China
|
+$298M |
| 3 |
Coatue Management
New York
|
+$169M |
| 4 |
BlackRock
New York
|
+$139M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$126M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$150M |
| 2 |
AG
Artal Group
Luxembourg
|
-$98.3M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$58.8M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$58.1M |
| 5 |
Primecap Management
Pasadena,
California
|
-$49.2M |
BNTX Hedge Fund Activity: Q2 2021 in Review
284 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in BioNTech (BNTX) for Q2 2021, worth a combined $7.84B — up 141% from $3.25B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new BNTX positions and 37 closed out — a net gain of 58 holders — while 72 added to existing stakes and 81 trimmed.
The largest buyer was Capital World Investors, adding an estimated $561M. The largest seller was Artisan Partners, cutting an estimated $150M.
- 284 institutional investors held BioNTech (BNTX) as of Q2 2021, up from 226 in Q1 2021.
- Funds reported $7.84B of BioNTech stock for Q2 2021, up 141% quarter-over-quarter.
- 95 funds opened new BioNTech positions in Q2 2021 and 37 closed out, a net change of +58 holders.
- The largest BioNTech buyer in Q2 2021 was Capital World Investors, an estimated $561M added.
- The largest BioNTech seller in Q2 2021 was Artisan Partners, an estimated $150M sold.
Based on aggregated 13F filings for Q2 2021.